HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lung transplantation for cystic fibrosis: immune system and autoimmunity.

AbstractBACKGROUND:
In the current study we focused on changes in the immune parameters of patients with CF after lung transplantation (Tx), with particular emphasis on the interaction of the immune system, infection, the autoimmune phenomenon observed in some CF patients, and immunosuppression.
MATERIAL AND METHODS:
Seven transplant patients with CF were investigated, 3 men and 4 women; the average age at Tx was 24.2 years (20.2-32.3). The parameters of both humoral immunity (immunoglobulins, complement, CRP, antinuclear and antineutrophil cytoplasmic antibodies) and cellular immunity (T and B lymphocytes, NK cells) were traced.
RESULTS:
We observed marked initial hyperimmunoglobulinemia, with a sharp drop in immunoglobulin levels within 1 month after Tx. Positivity for antineutrophil cytoplasmic antibodies (ANCA) was found in 3 patients before Tx. A strong ANCA positivity persisted 2 months after Tx despite deep introductory immunosuppression. In one patient ANCA positivity, after a transient negative result at months 2 and 12 after Tx, reappeared one year after Tx. The Burkholderia cepacia infections found in 2 patients proved to be lethal.
CONCLUSIONS:
In our series of CF lung transplant recipients, we found Burkholderia cepacia infection to be a risk factor. The robust appearance of autoantibodies and their persistent positivity for many months despite deep immunosuppression is a remarkable feature observed in some CF patients.
AuthorsA Sedivá, R Lischke, J Simonek, J Tkaczyk, V Vávrová, J Bartosová, P Pohunek, J Bartůnková, P Pafko
JournalMedical science monitor : international medical journal of experimental and clinical research (Med Sci Monit) 2001 Nov-Dec Vol. 7 Issue 6 Pg. 1219-23 ISSN: 1234-1010 [Print] United States
PMID11687733 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Adult
  • Autoimmunity
  • Cystic Fibrosis (therapy)
  • Female
  • Fluorescent Antibody Technique
  • Graft Rejection
  • Humans
  • Immunity, Cellular
  • Lung Transplantation (immunology)
  • Male

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: